New therapeutic agents marketed in 2019: Part 2 (June 2020 PT)

Activity Preview

This article is the second part of a series reviewing therapeutic agents approved by the FDA in 2019. The article includes a comparison of new medications with older medication(s) with similar properties and uses, as well as advantages and disadvantages.

Learning Objectives

At the completion of this knowledg-based activity, the participant will be able to:

  1. Identify the new therapeutic agents and explain their appropriate use.
  2. Identify the indications and mechanisms of action of the new agents.
  3. Identify the most important adverse events and other risks of the new therapeutic agents.
  4. State the route of administration for each new drug and the most important considerations for dosage and administration.
  5. Compare the new therapeutic agents with older medications to which they are most similar in properties and/or use, and identify the most important advantages and disadvantages of the new drugs.

Activity Type: Knowledge-based
Target Audience: Pharmacists and Pharmacy Technicians
Learning Level: 2

Accreditation Information

The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  This activity is approved for 2.0 contact hours of CPE credit (0.20 CEUs). The ACPE Universal Activity Number for this activity is 0202-0000-20-198-H01-P/T.  

To obtain credit for New Therapeautic Agents Marketed in 2019: Part 2, complete the assessment with a grade of 70% or better, complete the evaluation, and then claim credit. Participants need to have a valid pharmacist.com username and password to claim credit. After credit has been claimed, please visit CPE monitor for your transcript.

APhA's continuing pharmacy education policy allows two opportunities to successfully complete the continuing pharmacy education assessment. Please note that the questions may not appear in the same order as printed and only two attempts to pass the assessment will be granted.  The current policy of the APhA Education Department is to not release the correct answers to any of our CPE tests. This policy is intended to maintain the integrity of the CPE activity and the assessment.

Initial release date: June 1, 2020
Expiration date: June 1, 2023 - No credit can be earned after this date

Development

New Therapeautic Agents Marketed in 2019: Part 2 is a home-study continuing education activity for pharmacists developed by the American Pharmacists Association. © 2020 American Pharmacists Association

Disclosures

Mark S. Johnson, PharmD, BCPS, declares that he and his spouse hold stock in Merck & Co.

Daniel A. Hussar, PhD, FAPhA; Eric F. Hussar, MD, and APhA’s editorial staff declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For complete staff disclosures, please see the Education and Accreditation Information section at www.pharmacist.com/apha-disclosures.

Fee

There is no fee associated with this activity for members of the American Pharmacists Association. There is a $25 fee for nonmembers.

System Requirements

Computer and internet access are required to complete this activity.  Please visit our website to view the Technology System Requirements in order to have a positive learning experience.

Credit Information

Activity Number Credit Amount Accreditation Period
ACPE# 0202-0000-20-198-H01-P 0.2 CEUs June 01, 2020 - June 01, 2023
ACPE# 0202-0000-20-198-H01-T 0.2 CEUs June 01, 2020 - June 01, 2023